Literature DB >> 25762432

Clinical applications at ultrahigh field (7  T). Where does it make the difference?

Siegfried Trattnig1,2, Wolfgang Bogner1, Stephan Gruber1, Pavol Szomolanyi1,3, Vladimir Juras1,3, Simon Robinson1, Štefan Zbýň1, Stefan Haneder4.   

Abstract

Presently, three major MR vendors provide commercial 7-T units for clinical research under ethical permission, with the number of operating 7-T systems having increased to over 50. This rapid increase indicates the growing interest in ultrahigh-field MRI because of improved clinical results with regard to morphological as well as functional and metabolic capabilities. As the signal-to-noise ratio scales linearly with the field strength (B0 ) of the scanner, the most obvious application at 7 T is to obtain higher spatial resolution in the brain, musculoskeletal system and breast. Of specific clinical interest for neuro-applications is the cerebral cortex at 7 T, for the detection of changes in cortical structure as a sign of early dementia, as well as for the visualization of cortical microinfarcts and cortical plaques in multiple sclerosis. In the imaging of the hippocampus, even subfields of the internal hippocampal anatomy and pathology can be visualized with excellent resolution. The dynamic and static blood oxygenation level-dependent contrast increases linearly with the field strength, which significantly improves the pre-surgical evaluation of eloquent areas before tumor removal. Using susceptibility-weighted imaging, the plaque-vessel relationship and iron accumulation in multiple sclerosis can be visualized for the first time. Multi-nuclear clinical applications, such as sodium imaging for the evaluation of repair tissue quality after cartilage transplantation and (31) P spectroscopy for the differentiation between non-alcoholic benign liver disease and potentially progressive steatohepatitis, are only possible at ultrahigh fields. Although neuro- and musculoskeletal imaging have already demonstrated the clinical superiority of ultrahigh fields, whole-body clinical applications at 7 T are still limited, mainly because of the lack of suitable coils. The purpose of this article was therefore to review the clinical studies that have been performed thus far at 7 T, compared with 3 T, as well as those studies performed at 7 T that cannot be routinely performed at 3 T.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  7-T multi-nuclear spectroscopy and imaging; 7-T neurological applications; 7-T whole-body applications; 7 T; clinical 7-T studies; comparison studies 7 T versus 3 T; improved diagnosis for patients at 7 T; ultrahigh-field MR

Mesh:

Year:  2015        PMID: 25762432     DOI: 10.1002/nbm.3272

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  31 in total

1.  Intervertebral disc lesions: visualisation with ultra-high field MRI at 11.7 T.

Authors:  Nikolaus Berger-Roscher; Fabio Galbusera; Volker Rasche; Hans-Joachim Wilke
Journal:  Eur Spine J       Date:  2015-07-24       Impact factor: 3.134

Review 2.  Studying brain microstructure with magnetic susceptibility contrast at high-field.

Authors:  Jeff H Duyn
Journal:  Neuroimage       Date:  2017-02-24       Impact factor: 6.556

3.  Electrodynamics and radiofrequency antenna concepts for human magnetic resonance at 23.5 T (1 GHz) and beyond.

Authors:  Lukas Winter; Thoralf Niendorf
Journal:  MAGMA       Date:  2016-04-20       Impact factor: 2.310

4.  From ultrahigh to extreme field magnetic resonance: where physics, biology and medicine meet.

Authors:  Thoralf Niendorf; Markus Barth; Frank Kober; Siegfried Trattnig
Journal:  MAGMA       Date:  2016-06       Impact factor: 2.310

Review 5.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

Review 6.  Progress in Imaging the Human Torso at the Ultrahigh Fields of 7 and 10.5 T.

Authors:  Kamil Uğurbil; Pierre-Francois Van de Moortele; Andrea Grant; Edward J Auerbach; Arcan Ertürk; Russell Lagore; Jutta M Ellermann; Xiaoxuan He; Gregor Adriany; Gregory J Metzger
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-02       Impact factor: 2.266

7.  Topographical variations in zonal properties of canine tibial articular cartilage due to early osteoarthritis: a study using 7-T magnetic resonance imaging at microscopic resolution.

Authors:  Ji Hyun Lee; Farid Badar; John Matyas; Xianggui Qu; Yang Xia
Journal:  MAGMA       Date:  2016-02-17       Impact factor: 2.310

8.  Comparison of Routine Brain Imaging at 3 T and 7 T.

Authors:  Elisabeth Springer; Barbara Dymerska; Pedro Lima Cardoso; Simon Daniel Robinson; Christian Weisstanner; Roland Wiest; Benjamin Schmitt; Siegfried Trattnig
Journal:  Invest Radiol       Date:  2016-08       Impact factor: 6.016

Review 9.  7T Epilepsy Task Force Consensus Recommendations on the Use of 7T MRI in Clinical Practice.

Authors:  Giske Opheim; Anja van der Kolk; Karin Markenroth Bloch; Albert J Colon; Kathryn A Davis; Thomas R Henry; Jacobus F A Jansen; Stephen E Jones; Jullie W Pan; Karl Rössler; Joel M Stein; Maria C Strandberg; Siegfried Trattnig; Pierre-Francois Van de Moortele; Maria Isabel Vargas; Irene Wang; Fabrice Bartolomei; Neda Bernasconi; Andrea Bernasconi; Boris Bernhardt; Isabella Björkman-Burtscher; Mirco Cosottini; Sandhitsu R Das; Lucie Hertz-Pannier; Sara Inati; Michael T Jurkiewicz; Ali R Khan; Shuli Liang; Ruoyun Emily Ma; Srinivasan Mukundan; Heath Pardoe; Lars H Pinborg; Jonathan R Polimeni; Jean-Philippe Ranjeva; Esther Steijvers; Steven Stufflebeam; Tim J Veersema; Alexandre Vignaud; Natalie Voets; Serge Vulliemoz; Christopher J Wiggins; Rong Xue; Renzo Guerrini; Maxime Guye
Journal:  Neurology       Date:  2020-12-22       Impact factor: 9.910

10.  Common neurobiological correlates of resilience and personality traits within the triple resting-state brain networks assessed by 7-Tesla ultra-high field MRI.

Authors:  Tanja Veselinović; Irene Neuner; Dilsa Cemre Akkoc Altinok; Ravichandran Rajkumar; Dominik Nießen; Hasan Sbaihat; Margo Kersey; N Jon Shah
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.